Page 74 - Initial News Today

SponsorsOne Inc.: SponsorsOne Reveals Its Initial Portfolio of Products for Distilled Spirits Craft Distilled Spirits Market Is Poised To Grow $25.34 Billion Over The Next 4 Years With Whisky, Vodka And Gin Leading The Category WATERLOO, ON / ACCESSWIRE / January 12, 2021 / SponsorsOne Inc., (CSE:SPO)(Frankfurt:5SO)(OTC PINK:SPONF), a company that utilizes its proprietary platform that combines digital marketing, wholesale and retail distribution, branding, and operational & funding capital, g...

(1) - Clinical utility of Axumin (fluciclovine F 18) being investigated in expanded areas of cancer imaging - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced that the first patient has been dosed in its Phase 3 REVELATE clinical trial of 18F-fluciclovine, a positron emission tomography (PET) imaging radiopharmaceutical being studied for potential use in detecting recurrent brain meta...

NEW YORK, Jan. 11, 2021 /PRNewswire/ -- VectoIQ Acquisition Corp. II today announced that it closed its initial public offering of 34,500,000 units, which included the full exercise of the... | January 17, 2021

LONDON, Jan. 7, 2021 /PRNewswire/ -- SVF Investment Corp. (the "Company") announced today the pricing of its initial public offering of 52,500,000 units at $10 per unit. The units will be listed

Rentokil Initial Lifts FY20 Forecast For Adj. PBTA; Buys Environmental Pest Service LONDON (dpa-AFX) - Pest control firm Rentokil Initial Plc. (RTOKY.PK, RTO.L) Friday said it now expects the final outcome for the year 2020 to be slightly above the top end of the range of current market expectations for adjusted PBTA. The Company-compiled current range of analyst forecasts for adjusted PBTA for 2020 is 292 million pounds to 337 million pounds. The company previously indicated that full-year re...

Nanobiotix Announces Key Development Milestones for 2021 After Successful Nasdaq Initial Public Offering Nanobiotix will use a portion of the proceeds from the its IPO to launch its global phase III registration study in head and neck cancer in the United States in 2021 Following previously reported preliminary data regarding the ability of NBTXR3 to help transform anti-PD-1 non-responders into responders, the Company will provide the next update on its immuno-oncology phase I basket study eval...

Why Karma Cola founder is renewing focus on fair trade banana business All Good 6 Jan, 2021 06:46 PM 4 minutes to read Simon Coley carries a bunch of bananas in El Guabo, Ecuador. Photo / Supplied Aimee Shaw is a business reporter focusing on retail, small businessaimee.shaw@nzherald.co.nz@AceeyShaw The founder of global drinks company Karma Cola is expecting his fair trade banana business to do better than ever following initial disruption from the coronavirus pandemic. Simon Coley, w...

NeonMind Biosciences Inc: NeonMind Announces Closing of Oversubscribed Initial Public Offering and Exercise in Full of the Agents Over-Allotment Option NeonMind Biosciences Inc. completed the maximum offering for its initial public offering (the " IPO") of 46,000,000 units of NeonMind (the " Units") at a price to the public of $0.10 per Unit, including 6,000,000 in additional Units pursuant to the exercise in full of the over-allotment option. The gross proceeds from the IPO, before deducting ...

Regeneron Pharmaceuticals Inc said on Tuesday initial data from an ongoing study of its experimental antibody cocktail for use in some hospitalized COVID-19 patients show the therapy was sufficiently... | January 24, 2021

By Stephen Nakrosis Regeneron Pharmaceuticals Inc. on Tuesday said initial data from an ongoing Phase 1/2/3 clinical trial of its antibody cocktail in hospitalized Covid-19 patients... | January 23, 2021